5 total
The court approved the unopposed application to allocate approximately $160 million in excess settlement capital to increase benefits for Hepatitis C class members.
The Ontario Superior Court of Justice heard unopposed applications by the Joint Committee in the national Hepatitis C class actions (Parsons and Kreppner) to allocate approximately $160 million in "Excess Capital" from the settlement fund.
The Joint Committee proposed four recommendations to increase various benefits for approved class members and family members, including lump sum payments, loss of guidance/care/companionship awards, lost pension benefits, and loss of services rates.
The court granted the application, finding the proposed allocations reasonable, non-discriminatory, and consistent with the settlement agreement's purpose of bridging compensatory gaps.
Court allocates excess capital from Hepatitis C class action settlement trust to benefit Class Members.
The Attorney General of Canada and the Joint Committee representing Class Members brought competing applications regarding the allocation of approximately $236 million in excess capital held in the trust fund established by the 1986-1990 Hepatitis C Settlement Agreement.
Canada argued the excess capital should be returned to it, while the Joint Committee sought to allocate the funds to increase benefits for Class Members.
The court dismissed Canada's application, finding that the excess capital allocation provision was intended to provide an opportunity to bridge compensatory gaps for Class Members.
The court approved seven of the Joint Committee's nine recommendations for allocating the funds, including increases to fixed payments and loss of services compensation, to be implemented by way of special distribution.
A non-party to a settlement agreement lacks standing to intervene in surplus fund allocation.
The Steering Committee, an unincorporated group of physicians and scientists, sought to intervene in a joint hearing of motions concerning the allocation of actuarially unallocated funds from the 1986-1990 Hepatitis C Settlement Agreement.
The Committee proposed allocating funds to its "National HCV Initiative" which aimed to benefit all Canadians with HCV, not just class members.
The court dismissed the intervention request, finding that the Steering Committee was a stranger to both the Settlement Agreement and the underlying litigation, lacking privity of contract or any substantive right to participate in the administration of the settlement.
Authorization failed because no material change evidence supported the disclosure claim.
The Court allowed the appeal, holding that authorization under s. 225.4 of Quebec’s Securities Act requires a realistic chance of success and that the respondent failed to show credible evidence of a material change triggering timely disclosure obligations.
Court orders no costs for unopposed submissions in class action administration motion.
In the administration of a settled national class action concerning compensation claims, class counsel sought approval of a protocol allowing class members to submit late compensation claims despite the expiry of the original deadline under the settlement agreement.
The court had previously provisionally approved the protocol subject to approvals by courts in other jurisdictions.
The remaining issue concerned costs related to the protocol approval motion.
Only the moving party made submissions and requested that there be no order as to costs.
The court accepted the unopposed submission and ordered that there be no order as to costs.